Andrew N. Schiff, Director, 10% Owner at AGILE THERAPEUTICS INC (AGRX), bought 1,333,333 shares at $6.00 ($8.0M) on 2014-05-23, disclosed to the SEC on 2014-05-28.
Open-market purchase of $8.0M AGRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ACRS | SELL | 2022-10-19 | $1.7M | — | Filing → |
| ACRS | SELL | 2022-10-11 | $237K | — | Filing → |
| ACRS | SELL | 2022-10-06 | $1.5M | — | Filing → |